Justin G. Julander

Modified mRNA Vaccines Protect against Zika Virus Infection

Justin M. Richner, Sunny Himansu, Kimberly A. Dowd et al. · Cell · 2017 · 889 citations · Full text

Vaccination, Vaccine Development, Zika Virus Infection +4

Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model

Justin G. Julander, Venkatraman Siddharthan, J. T. Evans et al. · Antiviral Research · 2016 · 159 citations · Full text

Pathogenesis, Viral Pathogenesis, Antiviral Drug Development +10

Activity of T-705 in a Hamster Model of Yellow Fever Virus Infection in Comparison with That of a Chemically Related Compound, T-1106

Justin G. Julander, Kristiina Shafer, Donald F. Smee et al. · Antimicrobial Agents and Chemotherapy · 2008 · 141 citations · Full text

PSI-7851, a Pronucleotide of β- <scp>d</scp> -2′-Deoxy-2′-Fluoro-2′- <i>C</i> -Methyluridine Monophosphate, Is a Potent and Pan-Genotype Inhibitor of Hepatitis C Virus Replication

Angela M. Lam, Eisuke Murakami, Christine Espiritu et al. · Antimicrobial Agents and Chemotherapy · 2010 · 139 citations · Full text

Coitus-Free Sexual Transmission of Zika Virus in a Mouse Model

Chad S. Clancy, Arnaud J. Van Wettere, John D. Morrey et al. · Scientific Reports · 2018 · 119 citations · Full text